Kering's potential hiring of Luca de Meo, Renault's boss, signals an effort to address declining sales and rising debt, with Kering's value having dropped 75% since 2021. Investors view this as a positive step, demonstrated by a 12% surge in Kering's share price, driven by de Meo's turnaround expertise, which is expected to include cost-cutting measures and addressing Kering's planned acquisition of Valentino. De Meo's lack of luxury sector experience is noted, but his turnaround skills are seen as crucial for Kering's current challenges.
Kering's reported decision to appoint Renault CEO Luca de Meo is a significant strategic move aimed at addressing severe operational and financial challenges, including declining sales, over €10 billion in net debt, and a 75% erosion in market value since mid-2021. The market has responded favorably, with Kering's shares surging over 12% on the news, marking its best daily gain since 2008, reflecting investor confidence in de Meo's proven turnaround capabilities demonstrated at Renault, despite his lack of direct luxury sector experience. This leadership change, which sees Francois-Henri Pinault stepping back, is perceived as an acknowledgment of the urgent need for a new direction and potentially indicates that Kering's issues, extending beyond the underperformance of its star brand Gucci, are more substantial than externally perceived. De Meo is expected to spearhead an aggressive cost-reduction strategy, encompassing store closures, asset divestitures, and workforce reductions. A critical financial consideration will be managing the planned acquisition of the remaining 70% of Valentino, a deal potentially costing an additional €4 billion by 2028, with an option that could accelerate this purchase to as early as next May, possibly requiring partial payment in Kering shares, as stated by Kering's CFO Armelle Poulou.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment